CACCIAPAGLIA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 540
EU - Europa 163
AS - Asia 60
OC - Oceania 2
Totale 765
Nazione #
US - Stati Uniti d'America 535
SE - Svezia 74
SG - Singapore 36
DE - Germania 22
CN - Cina 17
IT - Italia 15
BE - Belgio 13
FR - Francia 13
GB - Regno Unito 12
FI - Finlandia 9
CA - Canada 5
IN - India 4
AU - Australia 2
CZ - Repubblica Ceca 2
AT - Austria 1
HR - Croazia 1
ID - Indonesia 1
IR - Iran 1
LT - Lituania 1
MN - Mongolia 1
Totale 765
Città #
Chandler 107
Nyköping 56
Fairfield 53
Ann Arbor 39
Ashburn 36
Seattle 28
Woodbridge 28
Houston 25
Singapore 23
Wilmington 18
Cambridge 17
Munich 15
Brussels 13
Lawrence 11
Roxbury 10
Helsinki 9
Dearborn 8
Paris 8
Brooklyn 7
New York 6
Des Moines 5
Los Angeles 5
Redwood City 5
Beijing 4
London 4
San Diego 4
Toronto 4
Inglewood 3
Milan 3
Naples 3
Pune 3
San Mateo 3
Santa Clara 3
Brno 2
Frankfurt am Main 2
Massa 2
Melbourne 2
Modugno 2
San Francisco 2
Shanghai 2
Washington 2
Ardabil 1
Augusta 1
Bari 1
Berlin 1
Boardman 1
Changsha 1
Clifton 1
Esslingen am Neckar 1
Florence 1
Hefei 1
Hounslow 1
Jakarta 1
Jiaxing 1
Kilburn 1
Kunming 1
Leawood 1
Mumbai 1
Nagold 1
Ottawa 1
Prescot 1
Princeton 1
Shaoxing 1
Shenyang 1
Taranto 1
Ulan Bator 1
Vienna 1
Zagreb 1
Totale 609
Nome #
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 93
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 91
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 87
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 83
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 74
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 70
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 60
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 36
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 35
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 31
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 30
Complete Hydatidiform Mole Mimicking Sacroiliitis 18
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 16
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 11
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 10
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 9
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 9
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast 8
Letters to the editors 8
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 8
Pulmonary arterial hypertension: Guidelines and unmet clinical needs 3
Totale 790
Categoria #
all - tutte 5.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020149 0 0 0 0 0 37 38 26 28 8 10 2
2020/202186 3 13 4 8 6 9 1 12 2 12 10 6
2021/2022119 3 3 4 3 11 10 7 6 8 14 15 35
2022/2023251 23 40 17 25 18 36 8 35 29 4 11 5
2023/202496 4 24 8 11 9 18 1 6 0 0 1 14
2024/202589 28 11 28 14 8 0 0 0 0 0 0 0
Totale 790